This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1AV Chobanian (1991) Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia coexist. Hypertension 18, 130–131.
3D Steinberg (1997) Oxidative modification of LDL and atherogenesis. Circulation 95, 1062–1071.
4H Esterbauer , J Gebicki , H Puhl & G Jurgens (1992) The role of lipid peroxidation and antioxidants in oxidative modifications of LDL. Free Radic Biol Med 13, 341–390.
6JA Berliner , MC Territo , A Sevanian , (1990) Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85, 1260–1266.
8W Palinski , ME Rosenfeld , S Yla-Herttuala , (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 86, 1372–1376.
9W Craig (1995) Autoantibodies against oxidized low density lipoportein: a review of clinical findings and assay methodology. J Clin Lab Anal 9, 70–74.
11T Lehtimaki , S Lehtinen , T Solakivi , (1999) Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler Thromb Vasc Biol 19, 23–27.
12T Inoue , T Uchida , H Kamishirado , (2001) Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol 37, 775–779.
13T Shoji , Y Nishizawa , M Fukumoto , (2000) Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 148, 171–177.
14S Yla-Herttuala , W Palinski , ME Rosenfeld , (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84, 1086–1095.
16PD Reaven , S Parthasarathy , BJ Grasse , E Miller , D Steinberg & J Witztum (1993) Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 91, 668–676.
17WQ Gradek , MT Harris , N Yahia , WW Davis , NA Le & WV Brown (2004) Polyunsaturated fatty acids acutely suppress antibodies to malondialdehyde-modified lipoproteins in patients with vascular disease. Am J Cardiol 93, 881–885.
18NA Le , X Li , S Kyung & WV Brown (2000) Evidence for the in vivo generation of oxidatively modified epitopes in patients with atherosclerotic endothelium. Metabolism 49, 1271–1277.
21FJ Tinahones , JM Gomez-Zumaquero , G Rojo-Martinez , (2002) Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population. Metabolism 51, 429–431.
22FJ Tinahones , JM Gomez-Zumaquero , L Garrido-Sanchez , (2005) Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population. J Lipid Res 46, 452–457.
23E Balada , J Ordi-Ros , L Matas , M Mauri , S Bujan & M Vilardell-Tarres (2002) Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population. Med Clin (Barc) 119, 161–165.
24A Festa , HP Kopp , G Schernthaner & EJ Menzel (1998) Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 41, 350–356.
25J Karvonen , M Paivansalo , YA Kesaniemi & S Horkko (2003) Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108, 2107–2112.
26S Horkko , DA Bird , E Miller , (1999) Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 103, 117–128.
27S Freigang , S Horkko , E Miller , JL Witztum & W Palinski (1998) Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol 18, 1972–1982.
28GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447–455.
30EB Schmidt , SD Kristensen , R De Caterina & DR Illingworth (1993) The effects of n-3 fatty acids on plasma lipids and lipoproteins and the other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis 103, 107–121.
31PH Levine , N Fisher , PB Schneider , (1989) Dietary supplementation with omega-3 fatty acids prolongs platelet survival in hyperlipidemic patients with atherosclerosis. Arch Intern Med 149, 1113–1116.
32P Singer , M Wirth , I Berger , (1985) Influence of serum lipids, lipoproteins and blood pressure of mackerel and herring diet in patients with type IV and V hyperlipoproteinemia. Atherosclerosis 56, 111–118.
35JL Witztum & D Steinberg (1991) Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88, 1785–1792.
37M Suzukawa , T Ishikawa , H Yoshida & H Nakamura (1995) Effect of in vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll Nutr 14, 46–52.
39MD Mesa , R Buckley , A Marieinibane & R Yaqoob (2004) Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on theoxidizability and thrombogenicity of low-density lipoprotein. Atherosclerosis 175, 333–343.
40S Nomura , S Kanazawa & S Fukuhara (2003) Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with type 2 diabetes mellitus. J Diabetes Complications 17, 153–159.
41O Johansen , I Seljeflot , AT Hostmark & H Arnesen (1999) The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 19, 1681–1686.
42F Thies , EA Miles , G Nebe-von-Caron , (2001) Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36, 1183–1193.
43CM Aguilera , MC Ramirez-Tortosa , MD Mesa , CL Ramirez-Tortosa & A Gil (2002) Sunflower, virgin-olive and fish oils differentially affect the progression of aortic lesions in rabbits with experimental atherosclerosis. Atherosclerosis 162, 335–344.
44FB Hu , L Bronner , WC Willett , (2002) Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 287, 1815–1821.
46JW Alexander (1998) Immunonutrition: the role of omega-3 fatty acids. Nutrition 14, 627–633.